Table 1.

Association of TROAP mRNA Expression With Clinicopathological Parameters in 52 HCC Specimens

Clinicopathologic Variables	n	TROAP mRNA Expression		p Value
		Low	High
Gender				0.9748
Male	45	26	19
Female	7	4	3
Age (years)				0.9125
≤60	47	27	20
>60	5	3	2
AFP (ng/ml)				0.7459
<200	13	8	5
≥200	39	22	17
Cirrhosis				0.6704
Absence	4	2	2
Presence	48	28	20
Child–Pugh Score				0.3405
A	34	18	16
B	18	12	6
Tumor size (cm)				0.0121*
<3	35	16	19
≥3	17	14	3
Capsular formation				0.3790
Presence	3	1	2
Absence	49	29	20
Tumor nodule number				0.0035†
Solitary	39	18	21
Multiple (≥2)	13	12	1
TNM stage				0.3309
I–II	39	21	18
III	13	9	4
BCLC stage				0.0412*
0–A	32	22	10
B–C	20	8	12
Edmondson–Steiner				0.6289
I–II	17	9	8
III–IV	35	21	14
Vein invasion				0.0186*
Presence	19	15	4
Absence	33	15	18

AFP, α-fetoprotein; BCLC, barcelona clinic liver cancer; HCC, hepatocellular cancer; TNM, tumor–node–metastasis classification; TROAP, trophinin-associated protein.

*p < 0.05; †p < 0.01.